Last reviewed · How we verify

NCT02567838

LIdocaine Gel Versus Plain Lubricating Gel for Pain Reduction During Transrectal Sonography (LIPS)

Completed Phase 3 Last updated 24 March 2017
What this trial tests

Phase 3 trial testing Lidocaine gel in Gynecologic Diseases in 80 participants. Completed in 1 August 2016.

Timeline
1 October 2015
Primary endpoint
1 August 2016
1 August 2016

Quick facts

Lead sponsorKangbuk Samsung Hospital
PhasePhase 3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposediagnostic
Enrollment80
Start date1 October 2015
Primary completion1 August 2016
Estimated completion1 August 2016
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Kangbuk Samsung Hospital

Who can join

Adults 15 to 80, female only, with Gynecologic Diseases. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The aim of this clinical trial is to evaluate the use of topical lidocaine gel in reducing pain associated with transrectal ultrasonography (TRS) in gynecologic field.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lidocaine gel

Trials testing the same drug.

Other recruiting trials for Gynecologic Diseases

Currently open trials in the same condition.

Other Kangbuk Samsung Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02567838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing